JOHANNA CAREY: Open Payments
NPI 1700840774 · HIGHLANDS RANCH, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,182 in 44 payments from 16 companies in 2025. Trend: 2023 $214 · 2024 $718 · 2025 $1,182
Food & beverage: $1,182
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 12 | $233 |
| Travere Therapeutics, Inc. | 3 | $180 |
| Novo Nordisk Inc | 6 | $163 |
| Calliditas Therapeutics US Inc. | 4 | $122 |
| AstraZeneca Pharmaceuticals LP | 3 | $68 |
| Otsuka America Pharmaceutical, Inc. | 2 | $58 |
| Mallinckrodt Hospital Products Inc. | 2 | $51 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $48 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $40 |
| SOBI, INC | 1 | $37 |
Products named: Fabhalta, Filspari, TARPEYO, Ozempic, JARDIANCE, LOKELMA, JYNARQUE, ACTHAR.
Industry payments across CO — which companies pay providers there.
